Cellular distribution of angiotensin-converting enzyme after myocardial infarction

Hypertension

Volumn 25, Issue 2, 1995, Pages 219-226

  Falkenhahn, Mechthild ^a   Franke, Folker ^b   Bohle, Rainer Maria ^b   Zhu, Yi Chun ^a   Stauss, Harald Martin ^a   Bachmann, Sebastian ^c   Danilov, Sergei ^d   Unger, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

angiotensin converting enzyme; endothelium; heart; macrophages; myocardial infarction

Indexed keywords

COLLAGEN TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LOCALIZATION; HEART INFARCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE REGENERATION;

EID: 0028847518     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.25.2.219     Document Type: Article

References (46)

1. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA. 1988;85:9386-9390.
2. Bernstein K, Martin B, Edwards A, Bernstein E. Mouse angiotensin converting enzyme is a protein composed of two homologous domains. J Biol Chem. 1989;264:11945-11951.
3. Kumar R, Thekkumkara T, Sen G. The mRNAs encoding the two angiotensin converting enzymes are transcribed from the same gene by a tissue specific choice of alternative transcription initiation sites J Biol Chem. 1991;266:3854-3862.
4. Shai S, Fishel R, Martin B, Berk B, Bernstein K. Bovine angiotensin converting enzyme cDNA cloning and regulation. Circ Res 1992;70:1274-1281.
5. Testut P, Soubrier F, Corvol P, Hubert C. Functional analysis of the human somatic angiotensin I-converting enzyme gene promoter Biochem J. 1993;293:843-848.
6. Goraya T, Kessler S, Kumar R, Douglas J, Sen G. Identification of positive and negative transcriptional regulatory elements of the rabbit angiotensin converting enzyme gene. Nucleic Acids Res 1994;22:1194-1201.
7. Yamada H, Fabris B, Allen A, Jackson B, Johnston C, Mendelsohn F. Localization of angiotensin converting enzyme in rat heart. Circ Res. 1991;68:141-149.
8. Pinto J, Viglione P, Saavedra J. Autoradiographic localization and quantification of rat heart angiotensin converting enzyme. Am J Hypertens. 1991;4:321-326.
9. Hirsch A, Talsness C, Schunkert H, Paul M, Dzau V. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 1991;69:475-482.
10. Schunkert H, Dzau V, Tang S, Hirsch A, Apstein C, Lorell B. Increased rat angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest. 1990;86:1913-1920.
11. Schunkert H, Jackson B, Tang S, Schoen F, Smits J, Apstein C, Lorell B. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation. 1993;87:1328-1339.
12. Fabris B, Jackson B, Kohzuki M, Perich R, Johnston CI. Increased cardiac angiotensin converting enzyme in rats with chronic heart failure. Clin Exp Pharmacol Physiol. 1990;17:309-314.
13. The AIRE Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.
14. The CONSENSUS II Study Group. Effect of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med. 1992;327:678-684.
15. Schoemaker R, Debets J, Struyker-Boudier H, Smits J. Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J Mol Cell Cardiol 1991;23:187-197.
16. Smits JFM, van Krimpen C, Schoemaker RG, Cleutjens JPM, Daemen MJAP. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 1992;20:772-778.
17. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res. 1993;27:341-348.
18. Stauss H, Zhu Y, Redlich T, Adamiak D, Mott A, Kregel K, Unger T. ACE inhibition in infarct-induced heart failure: bradykinin versus angiotensin II. J Cardiovasc Risk. 1994;1:255-262.
19. Johns TNP, Olson BJ. Experimental myocardial infarction, I: a method of coronary occlusion in small animals. Ann Surg. 1954; 140:675-682.
20. Danilov S, Faerman A, Printseva O, Martynov A, Sakharov I, Trakht I. Immunohistochemical study of angiotensin converting enzyme in human tissues using monoclonal antibodies. Histochemistry. 1987;87:487-490.
21. Danilov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L, Alhenc-Gelas F. Structure-function analysis of angioteasin I-converting enzyme using monoclonal antibodies. J Biol Chem. 1994;269:26806-26814.
22. Sibony M, Gasc J, Soubrier F, Alhenc-Gelas F, Corvol P. Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension. 1993;21:827-835.
23. Robinson A, White T, Mason D. MRC OX-43: a monoclonal antibody which reacts with all vascular endothelium in the rat except that of brain capillaries. Immunology. 1986;57:231-237
24. Wacker H, Radzun H, Parwaresch M. Ki-M2R, a new specific monoclonal antibody, discriminates tissue macrophages from reticulum cells and monocytes in vivo and in vitro. J Leukoc Biol. 1985;38:509-520.
25. Eghbali M, Blumenfeld O, Seifter S. Localisation of types I, III, and IV collagen mRNAs in rat heart cells by in situ hybridization. J Mol Cell Cardiol. 1989;21:103-113.
26. Foo T, Naylor I, Timmons M, Trejdosiewicz L. Intracellular actin as a marker for myofibroblasts in vitro. Lab Invest. 1992;67:727-733
27. Cordell JL, Falini B, Erber W, Ghosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H, Mason DY. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complex). J Histochem Cytochem. 1984;32:219-229.
28. Roth J, Saremaslani P, Warhol M, Heitz P. Improved accuracy in diagnostic immunohistochemistry, lectin histochemistry and in situ hybridization using a gold-labeled horseradish peroxidase antibody and silver intensification. Lab Invest. 1992;67:263-269.
29. Schäfer K, Gretz N, Bader M, Oberbäumer I, Eckardt K, Kriz W, Bachmann S. Characterization of the Han: SPRD rat model for hereditary polycystic kidney disease. Kidney Int. 1994;46:134-152
30. Nüsse T, Bohle R, Unger T, Danilov S, Falkenhahn M, Franke F. Zelluläre ACE Expression humanen Myokards bei Normotrophie, Hypertrophie und unter ACE-Inhibition. Z Kardiol. 1994;83(suppl 1): 100. Abstract.
31. Dasarathy Y, Lanzillo JJ, Fanburg BL. Stimulation of bovine pulmonary artery endothelial cell ACE by dexamethasone: involvement of steroid receptors. Am J Physiol. 1992;263:L645-L649.
32. Myers W, Honig C. Number and distribution of capillaries as determinants of myocardial oxygen tension. Am J Physiol. 1964;207: 653-660.
33. Hinman L, Stevens C, Matthay R, Bernhard J, Gee J. Angiotensin convertase activities in human alveolar macrophages: effects of cigarette smoking and sarcoidosis. Science. 1979;205:202-203.
34. Kozlowski S, Corr M, Takeshita T, Boyd L, Pendleton C, Germain R, Berzofsky J, Margulies D. Serum angiotensin I converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med. 1992;175:1417-1422.
35. Eisenlohr LC, Bacik I, Bennink JR, Bernstein K, Yewdell JW. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell. 1992;71:963-972.
36. Hashimoto K, Hirose M, Furukawa S, Hayakawa H, Kimura E. Changes in hemodynamics and bradykinin concentration in coronary sinus blood in experimental coronary occlusion. Jpn Heart J. 1977;18:679-689.
37. Martorana P, Kettenbach B, Breipohl G, Schölkens B. Reduction of infarct size by local angiotensin converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol. 1990;182: 395-396.
38. Gohlke P, Linz W, Schölkens B, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension. 1994;23:411-418.
39. Unger T, Mattfeldt T, Lamberty V, Bock P, Mall G, Linz W, Schölkens B, Gohlke P. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension. 1992; 20:478-482.
40. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury. J Clin Invest. 1994;93:339-346.
41. Powell J, Clozel J, Müller R, Kuhn H, Hefti F, Hosang M, Baumgartner H. Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989; 245:186-188.
42. Berk B, Vekshtein V, Gordon H, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13:305-314.
43. Naftilan A, Pratt R, Dzau V. Induction of platelet-derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1419-1424.
44. Metsärinne K, Stoll M, Gohlke P, Paul M, Unger T. Angiotensin II is antiproliferative for coronary endothelial cells in vitro. Pharm Pharmacol Lett. 1992;2:150-152.
45. Zhou G, Matsubara L, Brilla C, Tyagi S, Weber K. Angiotensin II and aldosterone regulate collagen turnover in cultured adult rat cardiac fibroblasts. J Mol Cell Cardiol. 1993;25:40. Abstract.
46. Johnston C, Mooser V, Sun Y, Fabris B. Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats. Clin Exp Pharmacol Physiol. 1991;18:107-110.